Cyclacel
Research & Development

Research & Development Overview

Cyclacel is a pioneer company in the field of cell cycle biology and our goal is to develop small molecule drugs that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, particularly those of high unmet medical need, with a vision to improve patient healthcare with orally available innovative medicines. We have generated several families of anticancer drugs that act on the cell cycle including sapacitabine, seliciclib and CYC065.

Clinical Drug Pipeline

Clinical Drug Pipeline

Research & Development